Results 181 to 190 of about 54,363 (314)
A data-driven AI framework for personalized diagnosis, prognosis, and therapeutic optimization in chronic disease management using multimodal big data analytics. [PDF]
Zhang Y, Song Z, Cai Q.
europepmc +1 more source
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain +10 more
wiley +1 more source
Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology. [PDF]
Huang HYR, Schneider KM, Schneider C.
europepmc +1 more source
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu +10 more
wiley +1 more source
How big data analytics can strengthen large-scale food fortification and biofortification decision-making: A scoping review. [PDF]
Walsh F +4 more
europepmc +1 more source
Real World-Big Data Analytics in Healthcare. [PDF]
Piovani D, Bonovas S.
europepmc +1 more source
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
Are Treatment Services Ready for the Use of Big Data Analytics and AI in Managing Opioid Use Disorder? [PDF]
Amer M +10 more
europepmc +1 more source
Big data analytics and knowledge discovery [PDF]
Bellatreche, Ladjel, Mohania, Mukesh K.
openaire +2 more sources
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source

